{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:34:25Z","timestamp":1789580065798,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020523","name":"United States Drug Enforcement Administration","doi-asserted-by":"publisher","award":["HHSF223201610079C"],"award-info":[{"award-number":["HHSF223201610079C"]}],"id":[{"id":"10.13039\/100020523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR003107"],"award-info":[{"award-number":["UL1TR003107"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004909"],"award-info":[{"award-number":["UM1TR004909"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.drugalcdep.2025.112672","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:11:13Z","timestamp":1744733473000},"page":"112672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice"],"prefix":"10.1016","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1517-6603","authenticated-orcid":false,"given":"Jared C.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0910-6879","authenticated-orcid":false,"given":"Jessica R.","family":"Thrush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9058-8765","authenticated-orcid":false,"given":"Taher M.","family":"Yusufali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1600-2894","authenticated-orcid":false,"given":"Hannah E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery H.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-1593","authenticated-orcid":false,"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2025.112672_bib1","first-page":"137","article-title":"Synthetic cannabinoid induced acute respiratory depression: case series and literature review","volume":"22","author":"Alon","year":"2017","journal-title":"Respir. Med Case Rep."},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112672_bib2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jms.1558","article-title":"Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?","volume":"44","author":"Auwarter","year":"2009","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib3","article-title":"Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations","volume":"Epub ahead of print","author":"Avram","year":"2023","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2016.06.027","article-title":"Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair novel object recognition in mice: behavioral, electrophysiological and neurochemical evidence","volume":"109","author":"Barbieri","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today's fentanyl crisis: prohibition's iron law, revisited","volume":"46","author":"Beletsky","year":"2017","journal-title":"Int J. Drug Policy"},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112672_bib6","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00213-022-06125-5","article-title":"Treatment of opioid overdose: current approaches and recent advances","volume":"239","author":"Britch","year":"2022","journal-title":"Psychopharmacology"},{"issue":"46","key":"10.1016\/j.drugalcdep.2025.112672_bib7","first-page":"939","article-title":"Notes from the field: severe illness associated with synthetic cannabinoid use - Brunswick, Georgia, 2013","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int J. Drug Policy"},{"issue":"1-2","key":"10.1016\/j.drugalcdep.2025.112672_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevNeurobiol.v16.i12.170","article-title":"Cannabinoid\/opioid crosstalk in the central nervous system","volume":"16","author":"Corchero","year":"2004","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib10","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2147\/JPR.S134330","article-title":"Cannabis as a substitute for prescription drugs - a cross-sectional study","volume":"10","author":"Corroon","year":"2017","journal-title":"J. Pain. Res"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112672_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/metabo12080773","article-title":"Similar 5F-APINACA metabolism between CD-1 mouse and human liver microsomes involves different P450 cytochromes","volume":"12","author":"Crosby","year":"2022","journal-title":"Metabolites"},{"issue":"23","key":"10.1016\/j.drugalcdep.2025.112672_bib12","doi-asserted-by":"crossref","first-page":"14619","DOI":"10.3390\/ijms232314619","article-title":"Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances","volume":"23","author":"Di Trana","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112672_bib13","first-page":"750","article-title":"The targeted analysis of new psychoactive substances in oral fluid through chromatographic-spectrometric methods: review of recent findings","volume":"26","author":"Di Trana","year":"2022","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173735","article-title":"Enantiomeric contributions to methamphetamine's bidirectional effects on basal and fentanyl-depressed respiration in mice","volume":"238","author":"Elder","year":"2024","journal-title":"Pharm. Biochem Behav."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib15","first-page":"121","article-title":"Heroin adulterated with the novel synthetic cannabinoid, 5F-MDMB-PINACA: a case series","volume":"4","author":"Ershad","year":"2020","journal-title":"Clin. Pr. Cases Emerg. Med"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.resp.2015.04.011","article-title":"Fentanyl effects on breath generation in C57BL\/6J and A\/J mouse strains","volume":"215","author":"Fechtner","year":"2015","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112672_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0090-9556(25)07486-0","article-title":"Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4","volume":"24","author":"Feierman","year":"1996","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112672_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tips.2016.12.003","article-title":"Synthetic pot: not your grandfather's marijuana","volume":"38","author":"Ford","year":"2017","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/dta.3170","article-title":"Development and validation of a rapid LC-MS\/MS method for the detection of 182 novel psychoactive substances in whole blood","volume":"14","author":"Giorgetti","year":"2022","journal-title":"Drug Test. Anal."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112672_bib21","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/dta.3035","volume":"13","author":"Grafinger","year":"2021","journal-title":"Drug Test. Anal."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112672_bib22","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/dta.3054","volume":"13","author":"Grafinger","year":"2021","journal-title":"Drug Test. Anal."},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112672_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamapsychiatry.2020.4321","article-title":"Methamphetamine overdose deaths in the US by sex and race and ethnicity","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112672_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/15563650.2017.1393082","article-title":"Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA","volume":"56","author":"Hermanns-Clausen","year":"2018","journal-title":"Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112672_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1254\/jphs.08244FP","article-title":"mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis","volume":"108","author":"Hojo","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112672_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2105\/AJPH.2022.307212","article-title":"Methamphetamine-Related Mortality in the United States: co-involvement of Heroin and Fentanyl, 1999-2021","volume":"113","author":"Hoopsick","year":"2023","journal-title":"Am. J. Public Health"},{"issue":"20","key":"10.1016\/j.drugalcdep.2025.112672_bib28","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.3390\/molecules26206190","article-title":"The spicy story of cannabimimetic indoles","volume":"26","author":"Howlett","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.forsciint.2019.02.005","article-title":"A case of 5F-ADB \/ FUB-AMB abuse: drug-induced or drug-related death?","volume":"297","author":"Ivanov","year":"2019","journal-title":"Forensic Sci. Int"},{"issue":"6408","key":"10.1016\/j.drugalcdep.2025.112672_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112672_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj. Prev."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106043","article-title":"The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: lessons from prior epidemics and clinical implications","volume":"170","author":"Jones","year":"2025","journal-title":"Neurosci. Biobehav Rev."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112672_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s12272-018-1055-x","article-title":"Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes","volume":"41","author":"Kong","year":"2018","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1874321801105010023","article-title":"Respiratory effects of opioids in perioperative medicine","volume":"5","author":"Koo","year":"2011","journal-title":"Open Anesth. J."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112672_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8516","article-title":"Critical illness secondary to synthetic cannabinoid ingestion","volume":"3","author":"Kourouni","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.devbrainres.2005.03.002","article-title":"Ontogeny of respiratory sensitivity and tolerance to the mu-opioid agonist fentanyl in rat","volume":"156","author":"Laferri\u00e8re","year":"2005","journal-title":"Brain Res Dev. Brain Res"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: preliminary results from a community drug checking program using point-of-care and confirmatory methods","author":"Laing","year":"2021","journal-title":"Int J. Drug Policy 90"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.340170","article-title":"Simultaneous quantification of 106 drugs or their metabolites in nail samples by UPLC-MS\/MS with high-throughput sample preparation: application to 294 real cases","volume":"1226","author":"Liu","year":"2022","journal-title":"Anal. Chim. Acta"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112672_bib39","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1021\/acschemneuro.7b00116","article-title":"Synthesis and pharmacological profiling of the metabolites of synthetic cannabinoid drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA","volume":"8","author":"Longworth","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112672_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12954-017-0183-9","article-title":"Rationale for cannabis-based interventions in the opioid overdose crisis","volume":"14","author":"Lucas","year":"2017","journal-title":"Harm Reduct. J."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112672_bib41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/15563650.2021.1975734","article-title":"Respiratory failure in confirmed synthetic cannabinoid overdose","volume":"60","author":"Manini","year":"2022","journal-title":"Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/01480540802587214","article-title":"Effect of exposure to fentanyl aerosol in mice on breathing pattern and respiratory variables","volume":"32","author":"Manral","year":"2009","journal-title":"Drug Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.122.001476","article-title":"Heroin- and fentanyl-induced respiratory depression in a rat plethysmography model: potency, tolerance, and sex differences","volume":"385","author":"Marchette","year":"2023","journal-title":"J. Pharm. Exp. Ther."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib44","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/ijms24021631","article-title":"The old and the new: cardiovascular and respiratory alterations induced by acute JWH-018 administration compared to \u03949-THC-A preclinical study in mice","volume":"24","author":"Marchetti","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112672_bib45","first-page":"e425","article-title":"The health threat of drugs of abuse adulteration by new psychoactive substances","volume":"170","author":"Minutillo","year":"2019","journal-title":"Clin. Ter."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50613-2","article-title":"Electrocortical changes associating sedation and respiratory depression by the opioid analgesic fentanyl","volume":"9","author":"Montandon","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112672_bib47","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/dta.3220","article-title":"Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services","volume":"14","author":"Monti","year":"2022","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112672_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13011-019-0195-4","article-title":"Higher doses of naloxone are needed in the synthetic opioid era","volume":"14","author":"Moss","year":"2019","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112672_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PAF.0000000000000622","article-title":"Xylazine, a veterinary tranquilizer, detected in 42 accidental fentanyl intoxication deaths","volume":"42","author":"Nunez","year":"2021","journal-title":"Am. J. Forensic Med Pathol."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103493","article-title":"Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services","volume":"100","author":"Oomen","year":"2022","journal-title":"Int J. Drug Policy"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib51","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.bjp.0705422","article-title":"Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats","volume":"140","author":"Padley","year":"2003","journal-title":"Br. J. Pharm."},{"issue":"11","key":"10.1016\/j.drugalcdep.2025.112672_bib52","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/pharmaceutics12111036","article-title":"Inhibitory effect of AB-PINACA, indazole carboxamide synthetic cannabinoid, on human major drug-metabolizing enzymes and transporters","volume":"12","author":"Park","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib54","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1523\/JNEUROSCI.1375-09.2009","article-title":"Opioids depress cortical centers responsible for the volitional control of respiration","volume":"29","author":"Pattinson","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112672_bib55","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bbrc.2018.03.028","article-title":"Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants","volume":"498","author":"Patton","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112672_bib56","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.bjp.0705874","article-title":"Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats","volume":"142","author":"Pfitzer","year":"2004","journal-title":"Br. J. Pharm."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112672_bib57","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/dta.3037","volume":"13","author":"Pike","year":"2021","journal-title":"Drug Test. Anal."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112672_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1369-1600.2008.00107.x","article-title":"Advances in the field of cannabinoid--opioid cross-talk","volume":"13","author":"Robledo","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib60","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/bja\/aeg279","article-title":"Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and \u03bc-opioid receptor deficient mice","volume":"91","author":"Romberg","year":"2003","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112672_bib61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00210-003-0787-3","article-title":"Analysis of the respiratory effects of cannabinoids in rats","volume":"368","author":"Schmid","year":"2003","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112672_bib62","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuropharm.2012.06.046","article-title":"AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid\/cannabinoid interaction studies","volume":"63","author":"Seely","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib63","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1164\/ajrccm\/142.4.895","article-title":"Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression","volume":"142","author":"Shook","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112672_bib64","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2174\/1389201018666170710184531","article-title":"Adulteration practices of psychoactive illicit drugs: an updated review","volume":"18","author":"Solimini","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108750","article-title":"The continued rise of methamphetamine use among people who use heroin in the United States","volume":"225","author":"Strickland","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/7854_2016_60","article-title":"Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites","volume":"32","author":"Tai","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112672_bib67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112672_bib68","first-page":"167","article-title":"Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation","volume":"82","author":"Tateishi","year":"1996","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib69","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7037a5","article-title":"Notes from the field: xylazine, a veterinary tranquilizer, identified as an emerging novel substance in drug overdose deaths \u2014 Connecticut, 2019\u20132020","volume":"70","author":"Thangada","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112672_bib70","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/dar.13237","article-title":"Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings","volume":"40","author":"Ti","year":"2021","journal-title":"Drug Alcohol Rev."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112672_bib71","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1248\/cpb.57.439","article-title":"Identification of a cannabinoid analog as a new type of designer drug in a herbal product","volume":"57","author":"Uchiyama","year":"2009","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib72","series-title":"Drug Market Trends: Cannabis and Opioids","author":"United Nations Office on Drugs and Crime World Drug Report","year":"2021"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112672_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","article-title":"Spice drugs as a new trend: mode of action, identification and legislation","volume":"197","author":"Vardakou","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114805","article-title":"Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated","volume":"195","author":"Varshneya","year":"2022","journal-title":"Biochem Pharm."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112672_bib75","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(24)37642-6","article-title":"Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A","volume":"286","author":"Vivian","year":"1998","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib76","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.drugalcdep.2025.112672_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0031-6997(25)06573-1","article-title":"Opioid receptors: autoradiography","volume":"35","author":"Wamsley","year":"1983","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107682","article-title":"CB1 cannabinoid receptor agonists induce acute respiratory depression in awake mice","volume":"214","author":"Watkins","year":"2025","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112672_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0196-9781(80)90099-6","article-title":"Anatomical and biochemical studies of the opioid peptides and related substances in the brain","volume":"1","author":"Watson","year":"1980","journal-title":"Peptides"},{"issue":"1_","key":"10.1016\/j.drugalcdep.2025.112672_bib80","doi-asserted-by":"crossref","first-page":"87S","DOI":"10.1177\/00333549211042834","article-title":"Biosurveillance of drug overdoses and substance misuse treated in selected emergency departments in Minnesota, 2017-2020","volume":"136","author":"Wiens","year":"2021","journal-title":"Public Health Rep."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112672_bib81","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3565(24)37496-8","article-title":"Structure-activity relationships of indole- and pyrrole-derived cannabinoids","volume":"285","author":"Wiley","year":"1998","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2025.112672_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109468","article-title":"Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal","volume":"236","author":"Wilson","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112672_bib83","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/dta.2607","article-title":"Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L-valine or L-tert-leucine","volume":"11","author":"Wouters","year":"2019","journal-title":"Drug Test. Anal."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:02:15Z","timestamp":1774530135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871625001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":83,"alternative-id":["S0376871625001255"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112672","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112672"}}